Psoriasis remission after gastric bypass surgery: a case report

Ornella De Pità, Francesca Lupi, Giuseppe Cianchini



Case reports suggest that gastric bypass surgery in patients with psoriasis may result in complete remission of the disease. A substantial weight loss is achieved in the months following surgery, which is likely to reduce psoriasis symptoms and risk of comorbidities. A 50-year-old man was followed in our Department for several years. He had severe plaque psoriasis requiring superpotent topical steroids and methotrexate. His medical history included morbid obesity (138 kg), dyslipidemia , hypertension and positive family history for psoriasis. He underwent gastric bypass surgery on November 2011. Eight months later, his weight decreased to 86 kg, and he noted a marked improvement in his psoriasis, with reduction of body surface area involvement. In our opinion weight loss may be a useful adjunctive therapy for obese patients with psoriasis.


Psoriasis; Gastric Bypass Surgery; Obesity

Full Text



  • Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009;361:496-509;
  • Faurschou A, Zachariae C, SkovL et al. Gastric bypass surgery :Improving psoriasi through a GLP-1dependent mechanism? Medical hypotheses 2011; 77: 1098-101;
  • Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose express of tumor necrosis factor-alpha: direct role in obesity linked insulin resistance. Science 1993; 259: 87-91;
  • Dandona P, Weinstock R, Thusu K, et al. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 1998; 83:2907-10;;
  • Higa-Sansone G, Szomstein S, Soto F, et al. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004;14: 1132-4;
  • Hossler EW, Maroon MS, Mowad CM. Gastric bypass surgery improves psoriasis. J Am Acad Dermatol 2011; 65: 198-200;
  • Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking onpsoriasis presentation and management. Arch Dermatol 2005; 141: 1527-34;
  • Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome [comment]. Lancet 2005; 365: 1415-28;
  • Katsuki A, Sumida Y, Murashima S, et al. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 859-62;;
  • Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis factor alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-15;
  • Chen YJ, Wu CY, Shen JL, et al. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 2008;144:1571-5;
  • Hamminga EA, Van der Lely AJ, Neumann HA, et al. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006; 67: 768-73;
  • Mattioli B, Straface E, Quaranta MG, et al. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol 2005; 174: 6820-8
  • Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5;
  • Wang Y, Chen J, Zhao Y, et al. Psoriasis is associated with increased levels of serum leptin. Br J Dermatol 2008; 158: 1134-5;
  • Takahashi H, Tsuji H, Takahashi I, et al. Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol 2008; 159: 1207-8
  • Cerman AA, Bozkurt S, Sav A, et al. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol 2008; 159: 820-6;
  • Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipo insular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg 2005; 15: 692-9;
  • Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897-901;
  • Santos-Alvarez J, Goberna R, Sanchez, et al. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999; 194: 6-11;
  • American Academy of Dermatology Work Group, Menter A, Korman NJ, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol 2011; 65: 137-74;


Abstract: 1084 views
HTML: 980 views
PDF: 203 views


  • There are currently no refbacks.